<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>chpha10qsb063007ex312.txt
<TEXT>

                                  Exhibit 31.2

          I, Xinhua Wu, the Chief  Financial  Officer of China Pharma  Holdings,
     Inc., certify that:

          1) I have  reviewed  this  quarterly  report  on Form  10-QSB of China
     Pharma Holdings, Inc.;

          2) Based on my  knowledge,  this  report  does not  contain any untrue
     statement of a material fact or omit to state a material fact  necessary to
     make the statements  made, in light of the  circumstances  under which such
     statements  were made, not misleading with respect to the period covered by
     this report;

          3)  Based  on  my  knowledge,  the  financial  statements,  and  other
     financial  information  included  in this  report,  fairly  present  in all
     material respects the financial  condition,  results of operations and cash
     flows of the small business issuer as of, and for, the periods presented in
     this report;

          4) The small business  issuer's other certifying  officer(s) and I are
     responsible  for  establishing  and  maintaining  disclosure  controls  and
     procedures  (as defined in Exchange Act Rules  13a-15(e) and 15d-15(e)) and
     internal control over financial reporting (as defined in Exchange Act Rules
     13a-15(f) and 15d-15(f)) for the small business issuer and have:

               a) Designed such disclosure  controls and  procedures,  or caused
          such  disclosure  controls  and  procedures  to be designed  under our
          supervision, to ensure that material information relating to the small
          business  issuer,  including its  consolidated  subsidiaries,  is made
          known to us by others within those entities,  particularly  during the
          period in which this report is being prepared;

               b) Designed such internal  control over financial  reporting,  or
          caused such internal  control over financial  reporting to be designed
          under our supervision,  to provide reasonable  assurance regarding the
          reliability  of financial  reporting and the  preparation of financial
          statements for external purposes in accordance with generally accepted
          accounting principles;

               c) Evaluated the  effectiveness  of the small  business  issuer's
          disclosure  controls and  procedures  and presented in this report our
          conclusions  about the  effectiveness  of the disclosure  controls and
          procedures,  as of the end of the period  covered by this report based
          on such evaluation; and

               d)  Disclosed  in this  report any  change in the small  business
          issuer's  internal  control over  financial  reporting  that  occurred
          during the small business issuer's most recent fiscal quarter that has
          materially affected, or is reasonably likely to materially affect, the
          small business issuer's internal control over financial reporting; and





<PAGE>


          5) The small business issuer's other certifying  officer(s) and I have
     disclosed,  based on our most recent  evaluation  of internal  control over
     financial reporting,  to the small business issuer's auditors and the audit
     committee of the small  business  issuer's  board of directors  (or persons
     performing the equivalent functions):

               a) All significant  deficiencies  and material  weaknesses in the
          design or operation of internal control over financial reporting which
          are reasonably  likely to adversely affect the small business issuer's
          ability   to  record,   process,   summarize   and  report   financial
          information; and

               b) Any fraud,  whether or not material,  that involves management
          or other  employees who have a significant  role in the small business
          issuer's internal control over financial reporting.



                                                       Date: August 10, 2007

                                                       By:     /s/ Xinhua Wu
                                                       -------------------------
                                                                   Xinhua Wu
                                                         Chief Financial Officer

</TEXT>
</DOCUMENT>
